Aug 03, 2023 / 12:30PM GMT
Operator
Greetings, and welcome to Aurinia Pharmaceuticals Inc. Second Quarter 2023 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, James Harrell, Investor Relations for Aurinia Pharmaceuticals. Thank you. You may begin.
James Archie Harrell - Aurinia Pharmaceuticals Inc. - Head of IR
Thank you, operator, and thanks, everyone, for joining today's call and webcast to review and discuss Aurinia's second quarter and 6-month 2023 financial and operational results. Joining me on the call this morning are Peter Greenleaf, Chief Executive Officer; and Joe Miller, our Chief Financial Officer.
This morning, Aurinia issued a press release announcing its financial results and operational highlights for the second quarter and 6 months ended June 30, 2023. In addition, the company filed its quarterly financial statements on Form 10-Q. For more information, please refer to Aurinia's filings with the U.S. Securities and Exchange Commission, which are also available on
Q2 2023 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Aug 03, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers